Day One Biopharmaceuticals, Inc.'s latest moves, explained simply — so you know why the numbers change.
Straight from SEC filings · updated 6 Aug 2026The company stopped being publicly traded on April 23, 2026, so you can no longer buy its stock.
A larger company decided to purchase Day One, which typically means existing shareholders get paid and the deal changes company ownership.
Day One shared information about its business with the public, helping investors understand what the company does.
Companies must tell investors how much money they made or lost and what assets they own each year.
The company announced its profits, losses, and financial performance for the entire year ending December 31, 2025.
Stocky reads Day One Biopharmaceuticals, Inc.'s official filings with the U.S. Securities and Exchange Commission (SEC) — the 8-K, 10-Q and 10-K reports every public company must file — and summarizes each one in plain English, with a link back to the original document.
Day One Biopharmaceuticals, Inc.'s most recent tracked filing was a 8-K on 23 Apr 2026: Merger with Servier completed, stock delisted from Nasdaq.
No. These event summaries are educational — generated from public SEC filings to help beginners understand what a company is doing. They are not buy or sell recommendations.
Educational, not financial advice. Company events summarized from public SEC filings.
Data as of 6 Aug 2026.